[go: up one dir, main page]

MX2013011623A - Regimenes de tratamiento. - Google Patents

Regimenes de tratamiento.

Info

Publication number
MX2013011623A
MX2013011623A MX2013011623A MX2013011623A MX2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A
Authority
MX
Mexico
Prior art keywords
treatment regimens
hsdd
compounds
subject
methods
Prior art date
Application number
MX2013011623A
Other languages
English (en)
Other versions
MX354989B (es
Inventor
Nicolas G Sitchon
Original Assignee
S1 Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S1 Biopharma Inc filed Critical S1 Biopharma Inc
Publication of MX2013011623A publication Critical patent/MX2013011623A/es
Publication of MX354989B publication Critical patent/MX354989B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere además a los compuestos, composiciones farmacéuticas y métodos para tratar el trastorno hipoactivo del deseo sexual (HSDD) en un sujeto.
MX2013011623A 2011-04-04 2012-04-03 Regimenes de tratamiento. MX354989B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161471505P 2011-04-04 2011-04-04
PCT/US2012/031991 WO2012138653A2 (en) 2011-04-04 2012-04-03 Treatment regimens

Publications (2)

Publication Number Publication Date
MX2013011623A true MX2013011623A (es) 2014-03-27
MX354989B MX354989B (es) 2018-03-28

Family

ID=46969773

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011623A MX354989B (es) 2011-04-04 2012-04-03 Regimenes de tratamiento.

Country Status (26)

Country Link
US (1) US20140038985A1 (es)
EP (2) EP2694065B1 (es)
JP (2) JP6279465B2 (es)
KR (3) KR102033699B1 (es)
CN (1) CN103635190B (es)
AU (3) AU2012240388A1 (es)
BR (1) BR112013025794A2 (es)
CA (1) CA2832306A1 (es)
CY (1) CY1120545T1 (es)
DK (1) DK2694065T3 (es)
EA (1) EA201391459A1 (es)
ES (1) ES2662570T3 (es)
HR (1) HRP20180417T1 (es)
HU (1) HUE036977T2 (es)
IL (1) IL228729A0 (es)
LT (1) LT2694065T (es)
MX (1) MX354989B (es)
NO (1) NO2746714T3 (es)
PL (1) PL2694065T3 (es)
PT (1) PT2694065T (es)
RS (1) RS57133B1 (es)
SG (2) SG10201609297VA (es)
SI (1) SI2694065T1 (es)
SM (1) SMT201800141T1 (es)
WO (1) WO2012138653A2 (es)
ZA (1) ZA201307760B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201800141T1 (it) * 2011-04-04 2018-05-02 S1 Biopharma Inc Composizione per il trattamento del disturbo del desiderio sessuale ipoattivo
EP2879680A4 (en) 2012-08-06 2016-06-01 S1 Biopharma Inc TREATMENT SCHEMES
CA3179754A1 (en) * 2020-04-08 2021-10-14 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine treatment for sexual dysfunction
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510074A (pt) * 2004-04-22 2007-10-16 Boehringer Ingelheim Int composições farmacêuticas para o tratamento de distúrbios sexuais ii
US20060004076A1 (en) * 2004-06-30 2006-01-05 Inflabloc Pharmaceuticals, Inc. Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
US7769770B2 (en) * 2004-07-14 2010-08-03 Microsoft Corporation Secondary index and indexed view maintenance for updates to complex types
JP4201747B2 (ja) * 2004-07-29 2008-12-24 三洋電機株式会社 自走式掃除機
EP1858516A1 (en) * 2005-03-04 2007-11-28 Boehringer Ingelheim International GmbH Pharmaceutical compositions for the treatment and/or prevention of depression
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
SMT201800141T1 (it) * 2011-04-04 2018-05-02 S1 Biopharma Inc Composizione per il trattamento del disturbo del desiderio sessuale ipoattivo

Also Published As

Publication number Publication date
HUE036977T2 (hu) 2018-08-28
CN103635190B (zh) 2016-09-07
BR112013025794A2 (pt) 2018-05-29
CA2832306A1 (en) 2012-10-11
ZA201307760B (en) 2015-01-28
KR20190120400A (ko) 2019-10-23
MX354989B (es) 2018-03-28
PL2694065T3 (pl) 2018-06-29
WO2012138653A3 (en) 2012-12-06
JP2014510138A (ja) 2014-04-24
EP3332780A1 (en) 2018-06-13
NO2746714T3 (es) 2018-02-03
AU2017203815A1 (en) 2017-06-22
ES2662570T3 (es) 2018-04-09
SI2694065T1 (en) 2018-06-29
AU2012240388A1 (en) 2013-10-24
KR101893551B1 (ko) 2018-08-30
KR102033699B1 (ko) 2019-10-17
SG194071A1 (en) 2013-11-29
HRP20180417T1 (hr) 2018-06-01
SG10201609297VA (en) 2016-12-29
US20140038985A1 (en) 2014-02-06
JP6279465B2 (ja) 2018-02-14
CN103635190A (zh) 2014-03-12
KR20180099910A (ko) 2018-09-05
EP2694065A4 (en) 2014-08-27
JP6563998B2 (ja) 2019-08-21
SMT201800141T1 (it) 2018-05-02
DK2694065T3 (en) 2018-03-19
CY1120545T1 (el) 2019-07-10
AU2012240388A8 (en) 2013-11-14
EA201391459A1 (ru) 2014-03-31
PT2694065T (pt) 2018-03-20
IL228729A0 (en) 2013-12-31
JP2018030870A (ja) 2018-03-01
KR20140031890A (ko) 2014-03-13
RS57133B1 (sr) 2018-07-31
EP2694065B1 (en) 2017-12-13
AU2018264030A1 (en) 2018-12-06
EP2694065A2 (en) 2014-02-12
KR102141519B1 (ko) 2020-08-06
LT2694065T (lt) 2018-04-10
WO2012138653A2 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
PH12015502075B1 (en) Treatment of cataplexy
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
MX370567B (es) Tratamiento de mielosupresion.
PT2729151T (pt) Composição farmacêutica, métodos de tratamento e suas utilizações
MX2020010991A (es) Composicion para la estimulacion ovarica controlada.
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
MX2014004074A (es) Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2.
MX2017000306A (es) Metodos para tratar hipotension.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
MX354989B (es) Regimenes de tratamiento.
PH12014502065A1 (en) Vesicular formulations
SG10201908587PA (en) Treatment regimens
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
EA201690445A1 (ru) Лечение рака
MX2015012505A (es) Métodos mejorados para tratamiento de grano con ozono.
MX2014006255A (es) Tratamientos neurologiocos con metaloporfirina.
HK1194683A (en) Treatment regimens
MX350868B (es) Medicamentos y metodos para tratar cancer.
MY184721A (en) Use of odiparcil in the treatment of a mucopolysaccharidosis
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes
PT3539540T (pt) Inibidor de sglt2 1-cloro-4-(beta-d-glucopiranos-1-il)-2-[4-((s)-tetra-hidrofurano-3-iloxi)-benzil]-benzeno em combinação com insulina para utilização num método para redução do risco de hipoglicemia
UA103980C2 (ru) Способ консервативного лечения апоплексии яичника с минимальным гемоперитонеумом
GB201116328D0 (en) Treatment for tumours
GB201118482D0 (en) Treating tumours

Legal Events

Date Code Title Description
FG Grant or registration